Jeffrey Karp
Gründer bei Altrixbio, Inc.
Profil
Jeffrey Karp is the founder of Altrixbio, Inc. which he founded in 2019 and where he currently holds the title of Director.
He is also the founder of Landsdowne Labs LLC, Molecular Infusions LLC, Skintifique, Alivio Therapeutics, Inc. Dr. Karp's current job is as a Venture Partner at Catalio Capital Management LP.
Dr. Karp's education history includes an undergraduate degree from McGill University and a doctorate degree from the University of Toronto, which he received in 2004.
Aktive Positionen von Jeffrey Karp
Unternehmen | Position | Beginn |
---|---|---|
Altrixbio, Inc.
Altrixbio, Inc. Pharmaceuticals: MajorHealth Technology Altrixbio, Inc. develops novel drugs that target metabolic diseases. The company is based in Cambridge, MA. The company was founded in 2019 by Ali Tavakkoli, Jeffrey Karp, Nancy Briefs. Nancy Briefs has been the CEO since 2019. | Gründer | 01.01.2019 |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - |
Skintifique
Skintifique Medical DistributorsDistribution Services Skintifique is a French skincare company that was founded by Jeffrey Karp. The private company specializes in developing innovative and effective skincare products for people with sensitive skin. Skintifique's products are designed to be hypoallergenic, non-comedogenic, and free from common allergens and irritants. The company's flagship product is the Protective Cream HPS, which provides long-lasting protection against environmental stressors and irritants. Skintifique is committed to using high-quality, safe, and sustainable ingredients in its products, and to providing its customers with exceptional customer service and support. | Gründer | - |
Molecular Infusions LLC
Molecular Infusions LLC Pharmaceuticals: OtherHealth Technology Molecular Infusions LLC operates as a biopharmaceutical company. It develops cannabis therapies through the deployment of proprietary technologies, scientific rigor, and results-driven innovation. The company was founded by Jeff Karp and Kevin Fisher in 2016 is headquartered in Franklin, MA. | Gründer | - |
Landsdowne Labs LLC
Landsdowne Labs LLC Medical/Nursing ServicesHealth Services Landsdowne Labs LLC engages in the provision of healthcare services. Its products include ChildLok, a button battery technology designed to deactivate batteries following accidental ingestion. The company was founded by Robert Langer, Melissa Fensterstock, and Jeff Karp and is headquartered in Stamford, CT. | Gründer | - |
Ehemalige bekannte Positionen von Jeffrey Karp
Unternehmen | Position | Ende |
---|---|---|
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | Gründer | - |
Ausbildung von Jeffrey Karp
McGill University | Undergraduate Degree |
University of Toronto | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Landsdowne Labs LLC
Landsdowne Labs LLC Medical/Nursing ServicesHealth Services Landsdowne Labs LLC engages in the provision of healthcare services. Its products include ChildLok, a button battery technology designed to deactivate batteries following accidental ingestion. The company was founded by Robert Langer, Melissa Fensterstock, and Jeff Karp and is headquartered in Stamford, CT. | Health Services |
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | Health Technology |
Molecular Infusions LLC
Molecular Infusions LLC Pharmaceuticals: OtherHealth Technology Molecular Infusions LLC operates as a biopharmaceutical company. It develops cannabis therapies through the deployment of proprietary technologies, scientific rigor, and results-driven innovation. The company was founded by Jeff Karp and Kevin Fisher in 2016 is headquartered in Franklin, MA. | Health Technology |
Skintifique
Skintifique Medical DistributorsDistribution Services Skintifique is a French skincare company that was founded by Jeffrey Karp. The private company specializes in developing innovative and effective skincare products for people with sensitive skin. Skintifique's products are designed to be hypoallergenic, non-comedogenic, and free from common allergens and irritants. The company's flagship product is the Protective Cream HPS, which provides long-lasting protection against environmental stressors and irritants. Skintifique is committed to using high-quality, safe, and sustainable ingredients in its products, and to providing its customers with exceptional customer service and support. | Distribution Services |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Altrixbio, Inc.
Altrixbio, Inc. Pharmaceuticals: MajorHealth Technology Altrixbio, Inc. develops novel drugs that target metabolic diseases. The company is based in Cambridge, MA. The company was founded in 2019 by Ali Tavakkoli, Jeffrey Karp, Nancy Briefs. Nancy Briefs has been the CEO since 2019. | Health Technology |